Search

Your search keyword '"F.T. Kerkhoff"' showing total 6 results
Start Over Author "F.T. Kerkhoff"
6 results on '"F.T. Kerkhoff"'

1. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017

Author

Carlien A. M. Bennebroek, F.T. Kerkhoff, Frank A.M. van den Dungen, Robert P.G. Feenstra, Mark A. H. B. M. van der Hoeven, Cathrien A. Eggink, Elke Kraal‐Biezen, Wes Onland, Nicoline E. Schalij-Delfos, Enrico Lopriore, Floris Groenendaal, Laurentius J. van Rijn, Koen P. Dijkman, Noël J.C. Bauer, Kasia Trzcionkowska, Frank A B A Schuerman, Elsbeth S.M. Voskuil‐Kerkhof, Arno van Heijst, Ruben S G M Witlox, Huibert J. Simonsz, Victor W. Renardel de Lavalette, Peter H. Dijk, J.U.M. Termote, Wouter Vehmeijer, René F. Kornelisse, Oogheelkunde, MUMC+: MA UECM Oogartsen MUMC (9), Kindergeneeskunde, RS: GROW - R4 - Reproductive and Perinatal Medicine, MUMC+: MA Medische Staf Kindergeneeskunde (9), Pediatrics, Ophthalmology, Graduate School, Neonatology, ARD - Amsterdam Reproduction and Development, Pediatric surgery, and Amsterdam Reproduction & Development (AR&D)

Subjects
Male, Vascular Endothelial Growth Factor A, Pediatrics, Visual Acuity, Angiogenesis Inhibitors, Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12], chemistry.chemical_compound, 0302 clinical medicine, retinopathy of prematurity, Netherlands, OUTCOMES, Laser Coagulation, infants born, Absolute number, treatment, Incidence, Retinal detachment, Gestational age, Retinopathy of prematurity, General Medicine, Treatment characteristics, Bevacizumab, Intravitreal Injections, Original Article, Female, guideline, medicine.medical_specialty, laser photocoagulation, Birth weight, Gestational Age, 03 medical and health sciences, medicine, Humans, Intravitreal bevacizumab, Retrospective Studies, business.industry, Infant, Newborn, Infant, Retinal, Original Articles, medicine.disease, eye diseases, Ophthalmology, chemistry, EXTREME, 030221 ophthalmology & optometry, sense organs, business, oxygen, 030217 neurology & neurosurgery, Follow-Up Studies
Abstract

Contains fulltext : 235444.pdf (Publisher’s version ) (Open Access) PURPOSE: Compare patients treated for Retinopathy of Prematurity (ROP) in two consecutive periods. METHODS: Retrospective inventory of anonymized neonatal and ophthalmological data of all patients treated for ROP from 2010 to 2017 in the Netherlands, subdivided in period (P)1: 1-1-2010 to 31-3-2013 and P2: 1-4-2013 to 31-12-2016. Treatment characteristics, adherence to early treatment for ROP (ETROP) criteria, outcome of treatment and changes in neonatal parameters and policy of care were compared. RESULTS: Overall 196 infants were included, 57 infants (113 eyes) in P1 and 139 (275 eyes) in P2, indicating a 2.1-fold increase in ROP treatment. No differences were found in mean gestational age (GA) (25.9 ± 1.7 versus 26.0 ± 1.7 weeks, p = 0.711), mean birth weight (791 ± 311 versus 764 ± 204 grams, p = 0.967) and other neonatal risk factors for ROP. In P2, the number of premature infants born

Published
2021

2. Increase in treatment of severe retinopathy of prematurity following a new national guideline

Author

Elke Kraal-Biezen, Kasia Trzcionkowska, Laurentius J. van Rijn, Wouter Vehmeijer, F.T. Kerkhoff, Elsbeth S M Voskuil-Kerkhof, Jacqueline U.M. Termote, Nicoline E. Schalij-Delfos, and Ophthalmology

Subjects
Pediatrics, medicine.medical_specialty, Letter, Treatment outcome, Gestational Age, Severity of Illness Index, 03 medical and health sciences, 0302 clinical medicine, Text mining, 030225 pediatrics, Severity of illness, Medicine, Combined Modality Therapy, Humans, Retinopathy of Prematurity, business.industry, Infant, Newborn, Infant, Gestational age, Retinopathy of prematurity, General Medicine, Newborn, medicine.disease, Infant newborn, National guideline, Ophthalmology, Treatment Outcome, 030221 ophthalmology & optometry, business, Retinopathy of Prematurity/diagnosis
Published
2018

3. Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands

Author

Wim A.J.G. Lemmens, Nicoline E. Schalij-Delfos, H J Simonsz, A J van Sorge, L.J. van Rijn, Jacqueline U.M. Termote, F.T. Kerkhoff, Ophthalmology, and Other Research

Subjects
Male, medicine.medical_specialty, Pediatrics, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Population, Nationwide survey, Screening Examination, Cellular and Molecular Neuroscience, Neonatal Screening, Vision Screening, Epidemiology, Humans, Medicine, Retinopathy of Prematurity, Prospective Studies, Stage (cooking), education, Netherlands, Quality of Health Care, education.field_of_study, business.industry, Incidence, Incidence (epidemiology), Infant, Newborn, Retinopathy of prematurity, medicine.disease, Sensory Systems, eye diseases, Natural history, Ophthalmology, Female, Health Services Research, business, Infant, Premature
Abstract

Item does not contain fulltext PURPOSE: Provide insight in natural history, screening and treatment policy of retinopathy of prematurity (ROP) in The Netherlands. METHODS: A multicentre, prospective, population-based study (NEDROP) included all preterm infants born in 2009 in The Netherlands fulfilling the inclusion criteria for ROP screening. Anonymised data from ophthalmologists, neonatologists and paediatricians were merged on identification number. RESULTS: Of 2033 reported infants, 1688 (83%) were screened for ROP. ROP stage was reported in 100%, zone in 94.4% and plus disease in 83%. ROP developed in 324 (19.2%), mild ROP (stage 1-2) in 294 (17.4%), severe ROP (stage 3 or more) in 30 (1.8%) and 17 (1%) were treated. The initial screening examination was not performed within the required 42 days in 641 (38%). Date for follow-up was recorded 1973 times and accomplished within 3 days from the planned date in 1957 (99.2%). The chance of not being screened increased from 12.9% without transfer to another hospital to 23.5, 18.5 and 25% after 1, 2, or 3 transfers, respectively. CONCLUSIONS: The incidence of severe ROP and infants treated was low. NEDROP emphasises that timing of initial examination and transfer to another hospital are issues of concern within the screening process.

Published
2014

4. Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria

Author

J.U.M. Termote, H J Simonsz, F.T. Kerkhoff, Nicoline E. Schalij-Delfos, I L A van Liempt, J L A M van Hillegersberg, Petronella G. M. Peer, A J van Sorge, L.J. van Rijn, Ophthalmology, and Other Research

Subjects
Male, Pediatrics, medicine.medical_specialty, Retina, Sepsis, Cellular and Molecular Neuroscience, Neonatal Screening, Risk Factors, medicine, Humans, Mass Screening, Retinopathy of Prematurity, Risk factor, Netherlands, business.industry, Incidence, Infant, Newborn, Gestational age, Retinopathy of prematurity, Guideline, medicine.disease, eye diseases, Sensory Systems, Ophthalmology, Logistic Models, Evaluation of complex medical interventions [NCEBP 2], Practice Guidelines as Topic, Female, business, Child health (paediatrics), Infant, Premature
Abstract

Item does not contain fulltext AIMS: To develop a new national screening guideline for retinopathy of prematurity (ROP). METHODS: Included were infants of the 2009 prospective ROP inventory in The Netherlands with gestational age (GA)

Published
2013

5. Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands

Author

F.T. Kerkhoff, Laurentius J. van Rijn, Petronella G. M. Peer, Arlette J. van Sorge, Jacqueline U.M. Termote, Huibert J. Simonsz, Nicoline E. Schalij-Delfos, Ophthalmology, and Other Research

Subjects
Male, Pediatrics, medicine.medical_specialty, Neonatal intensive care unit, Databases, Factual, Birth weight, Population, Gestational Age, Nitric Oxide, Risk Factors, Intensive Care Units, Neonatal, Administration, Inhalation, medicine, Birth Weight, Humans, Retinopathy of Prematurity, Prospective Studies, Risk factor, education, Netherlands, education.field_of_study, business.industry, Incidence (epidemiology), Infant, Newborn, Gestational age, Retinopathy of prematurity, Length of Stay, medicine.disease, Respiration, Artificial, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Bronchodilator Agents, Logistic Models, Bronchopulmonary dysplasia, Pediatrics, Perinatology and Child Health, Female, business, Infant, Premature
Abstract

Item does not contain fulltext OBJECTIVES: To study the incidence and risk factors for retinopathy of prematurity (ROP) in the Netherlands. STUDY DESIGN: Prospective, approximating population-based study that included infants with gestational age (GA) 28 days (OR 1.6, 95% CI 1.1-2.6, P = .03), and artificial ventilation >7 days (OR 1.6, 95% CI 1.1-2.5, P = .02). Prenatal glucocorticoids (OR 0.6, 95% CI 0.4-0.8, P < .001) and female sex (OR 0.7, 95% CI 0.5-0.99, P = .04) showed a lesser incidence of ROP. iNO remained significant after correction for all significant factors (OR 2.6, 95% CI 1.1-6.2, P = .03). CONCLUSION: In addition to established risk factors (GA, BW, stay at a neonatal intensive care unit >28 days, and artificial ventilation >7 days), treatment with iNO as risk factor for ROP is a novel finding.

Published
2013

6. Roth spots in pyridoxine dependent epilepsy

Author

Michèl A.A.P. Willemsen, Carola E P M Duijsters, F. J. J. Halbertsma, Cornelis Jakobs, F.T. Kerkhoff, and Levinus A. Bok

Subjects
Male, medicine.medical_specialty, Pathology, Neurology, Article, Pathogenesis, chemistry.chemical_compound, Internal medicine, Medicine, Effective diffusion coefficient, Humans, Pyridoxine-dependent epilepsy, Retina, Epilepsy, business.industry, Infant, Newborn, Retinal Hemorrhage, Retinal, General Medicine, medicine.disease, Magnetic Resonance Imaging, Tentorium, Ophthalmoscopy, medicine.anatomical_structure, Endocrinology, chemistry, business, Homeostasis
Abstract

Pyridoxine dependent epilepsy (PDE) is a rare metabolic defect in the degradation of lysine. The authors report a patient with metabolic and DNA confirmed PDE, on the fifth day of life ophthalmoscopy showed bilateral multiple white centred retinal haemorrhages, so called Roth spots. Roth spots are non-specific haemorrhagic signs that occur in a variety of conditions of acute systemic insults in homeostasis - most often infections- which relate to retinal capillary damage and the ensuing reparative process. No biochemical or microbiological signs of infection were present in blood and liquor. MRI of the brain showed an abnormal diffusion signal with increased apparent diffusion coefficient and little blood around the tentorium. The knowledge of the pathogenesis of PDE is still limited. The presence of Roth spots is suggestive for a pathogenic mechanism of vasogenic damage in PDE.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results